Literature DB >> 28848928

Personalization of Device Therapy - Prime Time for Peak Inspiratory Flow Rate.

Chee H Loh1, Jill A Ohar2.   

Abstract

Keywords:  chronic obstructive pulmonary disease; dry powder inhalers; peak inspiratory flow rate

Year:  2017        PMID： 28848928      PMCID： PMC5556908          DOI： 10.15326/jcopdf.4.3.2017.0155

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  31 in total

1.  In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates.

Authors:  M R Feddah; K F Brown; E M Gipps; N M Davies
Journal:  J Pharm Pharm Sci       Date:  2000 Sep-Dec       Impact factor: 2.327

2.  Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers.

Authors:  M E Broeders; J Molema; N A Vermue; H T Folgering
Journal:  Eur Respir J       Date:  2001-11       Impact factor: 16.671

3.  The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

Authors:  A R Clark; A M Hollingworth
Journal:  J Aerosol Med       Date:  1993

Review 4.  The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases.

Authors:  F M E Franssen; E F M Wouters; A M W J Schols
Journal:  Clin Nutr       Date:  2002-02       Impact factor: 7.324

Review 5.  Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.

Authors:  D L Ross; R K Schultz
Journal:  J Aerosol Med       Date:  1996

6.  Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease.

Authors:  R Gosselink; T Troosters; M Decramer
Journal:  J Cardiopulm Rehabil       Date:  2000 Nov-Dec       Impact factor: 2.081

7.  Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates.

Authors:  H Chrystyn
Journal:  Respir Med       Date:  2003-02       Impact factor: 3.415

8.  Measurement of peak inhalation rates with an in-check meter to identify an elderly patient's ability to use a turbuhaler.

Authors:  W M Nsour; A Alldred; J Corrado; H Chrystyn
Journal:  Respir Med       Date:  2001-12       Impact factor: 3.415

9.  The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.

Authors:  N Takabatake; H Nakamura; S Abe; S Inoue; T Hino; H Saito; H Yuki; S Kato; H Tomoike
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

10.  Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing.

Authors:  Theodoros Vassilakopoulos; Maziar Divangahi; George Rallis; Osama Kishta; Basil Petrof; Alain Comtois; Sabah N A Hussain
Journal:  Am J Respir Crit Care Med       Date:  2004-04-29       Impact factor: 21.405
View more
  4 in total

Review 1.  Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.

Authors:  Sohini Ghosh; Jill A Ohar; M Bradley Drummond
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-09-21       Impact factor: 2.849

Review 2.  Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD.

Authors:  Anthony D'Urzo; Kenneth R Chapman; James F Donohue; Peter Kardos; M Reza Maleki-Yazdi; David Price
Journal:  Pulm Ther       Date:  2019-03-13

3.  Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD.

Authors:  Cristina Represas-Represas; Luz Aballe-Santos; Alberto Fernández-García; Ana Priegue-Carrera; José-Luis López-Campos; Almudena González-Montaos; Maribel Botana-Rial; Alberto Fernández-Villar
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

Review 4.  Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD-A Systematic Scoping Review.

Authors:  Marika T Leving; Janwillem Kocks; Sinthia Bosnic-Anticevich; Richard Dekhuijzen; Omar S Usmani
Journal:  Biomedicines       Date:  2022-02-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.